The natural history of respiratory syncytial virus infection in cancer and transplant patients: Implications for management

Blood

Volumn 103, Issue 5, 2004, Pages 1611-1617

  Anaissie, Elias J ^a   Mahfouz, Tahsine H ^a   Aslan, Turan ^a   Pouli, Anastasia ^a   Desikan, Rahman ^a   Fassas, Athanasios ^a   Barlogie, Bart ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; LACTATE DEHYDROGENASE; RIBAVIRIN;

ADULT; AGED; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTUMN; CANCER CHEMOTHERAPY; CANCER PATIENT; DISEASE COURSE; DRUG INDICATION; FEMALE; HUMAN; KIDNEY FAILURE; LAVAGE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MUCOSA INFLAMMATION; MULTIPLE MYELOMA; NASOPHARYNX; PATIENT; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; TRANSPLANT PATIENT; VIRUS CULTURE; VIRUS INFECTION;

EID: 1442308160     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-05-1425     Document Type: Article

References (56)

1. Boeckh M, Berrey MM, Bowden RA, et al. Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants. J Infect Dis. 2001;184:350-354.
2. McCarthy AJ, Kingman HM, Kelly C, et al. The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation. Bone Marrow Transplant. 1999;24:1315-1322.
3. Nichols W, Gooley T, Boeckh M. Respiratory virus infections after hematopoietic SCT. Biol Blood Marrow Transplant. 2001;7:11S-15S.
4. Champlin R, Whimbey E. Community respiratory virus infections in bone marrow transplant recipients: The M.D. Anderson Cancer Center Experience. Biol Blood Marrow Transplant. 2001;7:8S-10S.
5. Ghosh S, Champlin RE, Ueno NT, et al. Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins. Bone Marrow Transplant. 2001;28:271-275.
6. Whimbey E, Couch RB, Englund JA, et al. Respiratory syncytial virus pneumonia in hospitalized adult patients with leukemia. Clin Infect Dis. 1995;21:376-379.
7. Whimbey E, Champlin RE, Englund JA, et al. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients. Bone Marrow Transplant. 1995;16:393-399.
8. Whimbey E, Englund JA, Couch RB. Community respiratory virus infections in immunocompromised patients with cancer. Am J Med. 1997;102:10-18; discussion 25-26.
9. Whimbey E, Ghosh S. Respiratory syncytial virus infections in immunocompromised adults. Curr Clin Top Infect Dis. 2000;20:232-255.
10. Gilchrist S, Torok TJ, Gary HE Jr, Alexander JP, Anderson LJ. National surveillance for respiratory syncytial virus, United States, 1985-1990. J Infect Dis. 1994;170:986-990.
11. Cane PA, Pringle CR. Molecular epidemiology of respiratory syncytial virus: a review of the use of reverse transcription-polymerase chain reaction in the analysis of genetic variability. Electrophoresis. 1995;16:329-333.
12. Saijo M, Takimoto M, Takahashi Y. Epidemiological study on respiratory syncytial virus lower respiratory tract infections in northern Hokkaido, Japan [in Japanese]. Kansenshogaku Zasshi. 1994;68:1-7.
13. Van der Poel WH, Brand A, Kramps JA, Van Oirschot JT. Respiratory syncytial virus infections in human beings and in cattle. J Infect. 1994;29:215-228.
14. Raad I, Abbas J, Whimbey E. Infection control of nosocomial respiratory viral disease in the immunocompromised host. Am J Med. 1997;102:48-52; discussion 53-44.
15. Wang EE, Law BJ, Boucher FD, et al. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr. 1996;129:390-395.
16. Shults RA, Baron S, Decker J, Deitchman SD, Connor JD. Health care worker exposure to aerosolized ribavirin: biological and air monitoring. J Occup Environ Med. 1996;38:257-263.
17. Aslan T, Fassas AB, Desikan R, et al. Patients with multiple myeloma may safely undergo autologous transplantation despite ongoing RSV infection and no ribavirin therapy. Bone Marrow Transplant. 1999;24:505-509.
18. Krilov LR, Lipson SM, Barone SR, et al. Evaluation of a rapid diagnostic test for respiratory syncytial virus (RSV): potential for bedside diagnosis. Pediatrics. 1994;93:903-906.
19. Freymuth F, Eugene G, Vabret A, et al. Detection of respiratory syncytial virus by reverse transcription-PCR and hybridization with a DNA enzyme immunoassay. J Clin Microbiol. 1995;33:3352-3355.
20. Barlogie B, Jagannath S, Desikan KR, et al. Total therapy with tandem transplants for newly diagnosed multiple myeloma. Blood. 1999;93:55-65.
21. Kehl SC, Henrickson KJ, Hua W, Fan J. Evaluation of the Hexaplex assay for detection of respiratory viruses in children. J Clin Microbiol. 2001;39:1696-1701.
22. Mufson MA, Chang V, Gill V, et al. The role of viruses, mycoplasmas and bacteria in acute pneumonia in civilian adults. Am J Epidemiol. 1967;86:526-544.
23. Hall CB, Long CE, Schnabel KC. Respiratory syncytial virus infections in previously healthy working adults. Clin Infect Dis. 2001;33:792-796.
24. Cubie HA, Duncan LA, Marshall LA, Smith NM. Detection of respiratory syncytial virus nucleic acid in archival postmortem tissue from infants. Pediatr Pathol Lab Med. 1997;17:927-938.
25. Anonymous. Update: respiratory syncytial virus activity-United States, 1994-95 season. MMWR Morb Mortal Wkly Rep. 1994;43:920-922.
26. Anonymous. Update: respiratory syncytial virus activity-United States, 1995-96 season. MMWR Morb Mortal Wkly Rep. 1995;44:900-902.
27. Anonymous. Update: respiratory syncytial virus activity-United States, 1996-97 season. MMWR Morb Mortal Wkly Rep. 1996;45:1053-1055.
28. Anonymous. Respiratory syncytial virus activity- United States, 2000-01 season. MMWR Morb Mortal Wkly Rep. 2002;51:26-28.
29. Resch B, Gusenleitner W, Mandl C, Muller W. Epidemiology of respiratory syncytial virus infection in Southern Austria. Pediatr Infect Dis J. 2000;19:587-588.
30. Washburne JF, Bocchini JA Jr, Jamison RM. Summertime respiratory syncytial virus infection: epidemiology and clinical manifestations. South Med J. 1992;85:579-583.
31. Cole PD, Suh JS, Onel K, et al. Benign outcome of RSV infection in children with cancer. Med Pediatr Oncol. 2001;37:24-29.
32. Krowka MJ, Rosenow EC III, Hoagland HC. Pulmonary complications of bone marrow transplantation. Chest. 1985;87:237-246.
33. Soubani AO, Miller KB, Hassoun PM. Pulmonary complications of bone marrow transplantation. Chest. 1996;109:1066-1077.
34. Wilhelm M, Kantarjian HM, O'Brien S, et al. Pneumonia during remission induction chemotherapy in patients with AML or MDS. Leukemia. 1996;10:1870-1873.
35. Crawford SW, Hackman RC, Clark JG. Open lung biopsy diagnosis of diffuse pulmonary infiltrates after marrow transplantation. Chest. 1988;94:949-953.
36. Robbins RA, Linder J, Stahl MG, et al. Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients. Am J Med. 1989;87:511-518.
37. Crawford SW, Clark JG. Bronchiolitis associated with bone marrow transplantation. Clin Chest Med. 1993;14:741-749.
38. Clark JG, Hansen JA, Hertz MI, et al. NHLBI workshop summary. Idiopathic pneumonia syndrome after bone marrow transplantation. Am Rev Respir Dis. 1993;147:1601-1606.
39. Papoff P, Fiorucci P, Ficuccilli F, et al. Characteristics of airway colonization in mechanically ventilated newborn infants [in Italian]. Pediatr Med Chir. 1997;19:413-416.
40. el-Ebiary M, Torres A, Fabregas N, et al. Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. An immediate postmortem histologic study. Am J Respir Crit Care Med. 1997;156:583-590.
41. Bhargava V, Tomashefski JF Jr, Stern RC, Abramowsky CR. The pathology of fungal infection and colonization in patients with cystic fibrosis. Human Pathol. 1989;20:977-986.
42. Ness MJ, Rennard SI, Vaughn WP, Ghafouri MA, Linder JA. Detection of Candida antigen in bronchoalveolar lavage fluid. Acta Cytol. 1988;32:347-352.
43. Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med. 2001;344:1917-1928.
44. Tal A, Bavilski C, Yohai D, et al. Dexamethasone and salbutamol in the treatment of acute wheezing in infants. Pediatrics. 1983;71:13-18.
45. van Woensel JB, Wolfs TF, van Aalderen WM, Brand PL, Kimpen JL. Randomised double blind placebo controlled trial of prednisolone in children admitted to hospital with respiratory syncytial virus bronchiolitis. Thorax. 1997;52:634-637.
46. Garrison MM, Christakis DA, Harvey E, Cummings P, Davis RL. Systemic corticosteroids in infant bronchiolitis: a meta-analysis. Pediatrics. 2000;105:1-6.
47. Klassen TP, Craig WR, Moher D, et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA. 1998;279:1629-1632.
48. Klassen TP, Sutcliffe T, Watters LK, et al. Dexamethasone in salbutamol-treated inpatients with acute bronchiolitis: a randomized, controlled trial. J Pediatr. 1997;130:191-196.
49. Johnson DW, Jacobson S, Edney PC, et al. A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup. N Engl J Med. 1998;339:498-503.
50. Ausejo M, Saenz A, Pham B, et al. Glucocorticoids for croup. Cochrane Database Syst Rev. 2000;2:CD001955.
51. Ausejo M, Saenz A, Pham B, et al. The effectiveness of glucocorticoids in treating croup: meta-analysis. BMJ. 1999;319:595-600.
52. Prince GA, Mathews A, Curtis J, Porter DD. Treatment of respiratory syncytial virus bronchiolitis and pneumonia in a cotton rat model with systemically administered monoclonal antibody (palivizumab) and glucocorticosteroid. J Infect Dis. 2000;182:1326-1330.
53. Randolph AG, Wang EE. Ribavirin for respiratory syncytial virus lower respiratory tract infection. A systematic overview. Arch Pediatr Adolesc Med. 1996;150:942-947.
54. Selvey LA, Whitby M, Johnson B. Nosocomial methicillin-resistant Staphylococcus aureus bacteremia: is it any worse than nosocomial methicillin-sensitive Staphylococcus aureus bacteremia? Infect Control Hosp Epidemiol. 2000;21:645-648.
55. Anonymous. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994. Centers for Disease Control and Prevention. MMWR Recomm Rep. 1994;43:1-132.
56. Dykewicz C, Jaffe H, Kaplan J. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transport. 2000;6:659-713;715;717-727; quiz 729-733.